2,696
Views
57
CrossRef citations to date
0
Altmetric
Research Papers

In-situ tumor vaccination: Bringing the fight to the tumor

, , , &
Pages 1901-1909 | Received 26 Dec 2014, Accepted 05 May 2015, Published online: 11 Aug 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Kristian M. Koller, Heath B. Mackley, Jason Liu, Henry Wagner, Giampaolo Talamo, Todd D. Schell, Colette Pameijer, Rogerio I. Neves, Bryan Anderson, Kathleen M. Kokolus, Carol A. Mallon & Joseph J. Drabick. (2017) Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone. Cancer Biology & Therapy 18:1, pages 36-42.
Read now
Nina Werthmöller, Benjamin Frey, Michael Rückert, Michael Lotter, Rainer Fietkau & Udo S. Gaipl. (2016) Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo. International Journal of Hyperthermia 32:1, pages 23-30.
Read now
Kenneth E Ugen & David B Weiner. (2015) DNA vaccines 2014 meeting: Highlights and overview. Human Vaccines & Immunotherapeutics 11:8, pages 1887-1888.
Read now

Articles from other publishers (54)

Adam A. Walters, Abrar Ali, Julie Tzu-Wen Wang & Khuloud T. Al-Jamal. (2022) Anti-tumor antibody isotype response can be modified with locally administered immunoadjuvants. Drug Delivery and Translational Research 13:7, pages 2032-2040.
Crossref
Qinfu Dan, Yang Yang & Hong Ge. (2023) cGAS-STING Pathway as the Target of Immunotherapy for Lung Cancer. Current Cancer Drug Targets 23:5, pages 354-362.
Crossref
Arman Kalami, Mehdi Shahgolzari, Ahmad Yari Khosroushahi & Steven Fiering. (2023) Combining in situ vaccination and immunogenic apoptosis to treat cancer . Immunotherapy 15:5, pages 367-381.
Crossref
Jie Wang, Shivani Sud, Yanli Qu, Liantao Li, Jiajie Zhang, David Marron, Nicole Michelle Knape, Isaiah James Kim, Kyle Thomas Wagner, Tian Zhang, Yuxia Zhao, Genyan Guo & Andrew Z. Wang. (2023) Post-irradiation intratumoral heterogeneity modulates response to immune checkpoint inhibition therapy in a murine melanoma model. Neoplasia 36, pages 100864.
Crossref
Yanhong Chu & Baorui Liu. 2023. New Topics in Vaccine Development [Working Title]. New Topics in Vaccine Development [Working Title].
Ava Saidian, Isabella Dolendo, Andrew Sharabi, Tyler F. Stewart, Brent Rose, Rana R. McKay, Aditya Bagrodia & Amirali Salmasi. (2022) The Current and Future Promises of Combination Radiation and Immunotherapy for Genitourinary Cancers. Cancers 15:1, pages 127.
Crossref
Lianru Zhang, Xipeng Zhou, Huizi Sha, Li Xie & Baorui Liu. (2022) Recent Progress on Therapeutic Vaccines for Breast Cancer. Frontiers in Oncology 12.
Crossref
Yuxiang Wang, Jing Chen, Rumeng Duan, Rong Gu, Weiran Wang, Jinhui Wu, Huibo Lian, Yiqiao Hu & Ahu Yuan. (2022) High‐ Z ‐Sensitized Radiotherapy Synergizes with the Intervention of the Pentose Phosphate Pathway for In Situ Tumor Vaccination . Advanced Materials 34:13.
Crossref
Caitlyn L. Miller, Idit Sagiv-Barfi, Patrick Neuhöfer, Debra K. Czerwinski, Steven E. Artandi, Carolyn R. Bertozzi, Ronald Levy & Jennifer R. Cochran. (2022) Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression. Cell Chemical Biology 29:3, pages 451-462.e8.
Crossref
Jun Kim, Seounghun Kang, Kyoung Won Kim, Myeong-Gang Heo, Dae-In Park, Joon-Hyung Lee, Nam Ju Lim, Dal-Hee Min & Cheolhee Won. (2022) Nanoparticle delivery of recombinant IL-2 (BALLkine-2) achieves durable tumor control with less systemic adverse effects in cancer immunotherapy. Biomaterials 280, pages 121257.
Crossref
Shama Parveen & Monisha Banerjee. 2022. Handbook of Microbial Nanotechnology. Handbook of Microbial Nanotechnology 375 383 .
Sachie Kiryu, Zensho Ito, Machi Suka, Tsuuse Bito, Shin Kan, Kan Uchiyama, Masayuki Saruta, Taigo Hata, Yuki Takano, Shuichi Fujioka, Takeyuki Misawa, Takashi Yamauchi, Hiroyuki Yanagisawa, Nobuhiro Sato, Toshifumi Ohkusa, Haruo Sugiyama & Shigeo Koido. (2021) Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma. BMC Cancer 21:1.
Crossref
Brandon J. Burbach, Stephen D. O’Flanagan, Qi Shao, Katharine M. Young, Joseph R. Slaughter, Meagan R. Rollins, Tami Jo L. Street, Victoria E. Granger, Lalit. K. Beura, Samira M. Azarin, Satish Ramadhyani, Bruce R. Forsyth, John C. Bischof & Yoji Shimizu. (2021) Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells. Nature Communications 12:1.
Crossref
Lixiao Liu, Luya Cai, Xuedan Du, Jinduo Zhao, Ye Zhao, Chengyang Zou, Shanshan Yu, Chunhong Zhang, Piaopiao Ye, Xiaoping Su, Xiaojian Yan & Wenfeng Li. (2021) Anti-tumour effect of in situ vaccines combined with VEGFR inhibitors in the treatment of metastatic cervical cancer. International Immunopharmacology 101, pages 108302.
Crossref
Alexander A. Pieper, Luke M. Zangl, Dan V. Speigelman, Arika S. Feils, Anna Hoefges, Justin C. Jagodinsky, Mildred A. Felder, Noah W. Tsarovsky, Ian S. Arthur, Ryan J. Brown, Jen Birstler, Trang Le, Peter M. Carlson, Amber M. Bates, Jacquelyn A. Hank, Alexander L. Rakhmilevich, Amy K. Erbe, Paul M. Sondel, Ravi B. Patel & Zachary S. Morris. (2021) Radiation Augments the Local Anti-Tumor Effect of In Situ Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in Immunologically Cold Tumor Models. Frontiers in Immunology 12.
Crossref
Urska Kamensek, Katja Ursic, Bostjan Markelc, Maja Cemazar, Vita Setrajcic Dragos & Gregor Sersa. (2021) Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNFα and IL-12 gene electrotransfer. Bioelectrochemistry 140, pages 107831.
Crossref
James Spicer, Aurélien Marabelle, Jean-Francois Baurain, Nina Louise Jebsen, Dag Erik Jøssang, Ahmad Awada, Rebecca Kristeleit, Delphine Loirat, George Lazaridis, Christiane Jungels, Paal Brunsvig, Berit Nicolaisen, Andrew Saunders, Hamina Patel, Jérôme Galon, Fabienne Hermitte, Ketil André Camilio, Brynjar Mauseth, Vibeke Sundvold, Baldur Sveinbjørnsson & Øystein Rekdal. (2021) Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors. Clinical Cancer Research 27:10, pages 2755-2763.
Crossref
Katja Ursic, Spela Kos, Urska Kamensek, Maja Cemazar, Simona Miceska, Bostjan Markelc, Simon Bucek, Barbara Staresinic, Veronika Kloboves Prevodnik, Richard Heller & Gregor Sersa. (2021) Potentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status. Journal of Controlled Release 332, pages 623-635.
Crossref
Sujit S. Nair, Rachel Weil, Zachary Dovey, Avery Davis & Ashutosh K. Tewari. (2020) The Tumor Microenvironment and Immunotherapy in Prostate and Bladder Cancer. Urologic Clinics of North America 47:4, pages e17-e54.
Crossref
Veronica Mollica, Matteo Santoni, Vincenzo Di Nunno, Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Nicola Battelli, Rodolfo Montironi & Francesco Massari. (2020) Immunotherapy and Radiation Therapy in Renal Cell Carcinoma. Current Drug Targets 21:14, pages 1463-1475.
Crossref
Justin C. Jagodinsky, Paul M. Harari & Zachary S. Morris. (2020) The Promise of Combining Radiation Therapy With Immunotherapy. International Journal of Radiation Oncology*Biology*Physics 108:1, pages 6-16.
Crossref
Vered Domankevich, Margalit Efrati, Michael Schmidt, Eran Glikson, Fairuz Mansour, Amit Shai, Adi Cohen, Yael Zilberstein, Elad Flaisher, Razvan Galalae, Itzhak Kelson & Yona Keisari. (2020) RIG-1-Like Receptor Activation Synergizes With Intratumoral Alpha Radiation to Induce Pancreatic Tumor Rejection, Triple-Negative Breast Metastases Clearance, and Antitumor Immune Memory in Mice. Frontiers in Oncology 10.
Crossref
Hanwen Li, Jiayun Yu, Yongyao Wu, Bin Shao & Xiawei Wei. (2020) In situ antitumor vaccination: Targeting the tumor microenvironment. Journal of Cellular Physiology 235:7-8, pages 5490-5500.
Crossref
Heejun Shin & Kun Na. (2020) Cancer-Targetable pH-Sensitive Zinc-Based Immunomodulators Combined with Photodynamic Therapy for in Situ Vaccination . ACS Biomaterials Science & Engineering 6:6, pages 3430-3439.
Crossref
Sandra Demaria & Silvia C Formenti. (2020) The abscopal effect 67 years later: from a side story to center stage. The British Journal of Radiology 93:1109, pages 20200042.
Crossref
Rachid Bouzid, Maikel Peppelenbosch & Sonja I. Buschow. (2020) Opportunities for Conventional and In Situ Cancer Vaccine Strategies and Combination with Immunotherapy for Gastrointestinal Cancers, A Review. Cancers 12:5, pages 1121.
Crossref
Michael-Joseph Gorbet & Ashish Ranjan. (2020) Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy. Pharmacology & Therapeutics 207, pages 107456.
Crossref
Jason Liu, Cong Xu, Junjia Zhu, Jeffrey Sivik, Joseph J. Drabick & Heath B. Mackley. (2020) Identifying the Optimal Fractionation Schedules for Improved Response Rates and Survival in Patients with Metastatic Melanoma Treated with Ipilimumab and Radiotherapy. Current Cancer Therapy Reviews 16:1, pages 78-85.
Crossref
Yang Liu, William N. Crowe, Lulu Wang, Yong Lu, W. Jeffrey Petty, Amyn A. Habib & Dawen Zhao. (2019) An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases. Nature Communications 10:1.
Crossref
Dmitriy Zamarin. (2019) Immunomodulatory Drugs Encoded by Oncolytic Viruses: Is the Whole Greater Than the Sum?. Molecular Therapy 27:11, pages 1874-1877.
Crossref
Chao Wang, Steven N. Fiering & Nicole F. Steinmetz. (2019) Cowpea Mosaic Virus Promotes Anti‐Tumor Activity and Immune Memory in a Mouse Ovarian Tumor Model. Advanced Therapeutics 2:5, pages 1900003.
Crossref
Jihoon Kim, Margaret P. Manspeaker & Susan N. Thomas. (2019) Augmenting the synergies of chemotherapy and immunotherapy through drug delivery. Acta Biomaterialia 88, pages 1-14.
Crossref
Jason Liu & Heath B. Mackley. (2019) Combining immunotherapy with radiation therapy to induce the abscopal response: What clinical and treatment variables matter?. Applied Radiation Oncology, pages 14-19.
Crossref
Heejun Shin & Kun Na. (2019) In situ vaccination with biocompatibility controllable immuno-sensitizer inducing antitumor immunity. Biomaterials 197, pages 32-40.
Crossref
Anandaroop Mukhopadhyay, Jocelyn Wright, Shawna Shirley, David A. Canton, Christoph Burkart, Richard J. Connolly, Jean S. Campbell & Robert H. Pierce. (2018) Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy. Gene Therapy 26:1-2, pages 1-15.
Crossref
Neil S. Forbes, Robert S. Coffin, Liang Deng, Laura Evgin, Steve Fiering, Matthew Giacalone, Claudia Gravekamp, James L. Gulley, Hal Gunn, Robert M. Hoffman, Balveen Kaur, Ke Liu, Herbert Kim Lyerly, Ariel E. Marciscano, Eddie Moradian, Sheryl Ruppel, Daniel A. Saltzman, Peter J. Tattersall, Steve Thorne, Richard G. Vile, Halle Huihong Zhang, Shibin Zhou & Grant McFadden. (2018) White paper on microbial anti-cancer therapy and prevention. Journal for ImmunoTherapy of Cancer 6:1.
Crossref
Chunsong Yu & Haipeng Liu. 2018. Immunoregulatory Aspects of Immunotherapy. Immunoregulatory Aspects of Immunotherapy.
Veronika Caisová, Ondřej Uher, Pavla Nedbalová, Ivana Jochmanová, Karolína Kvardová, Kamila Masáková, Gabriela Krejčová, Lucie Paďouková, Jindřich Chmelař, Jan Kopecký & Jan Ženka. (2018) Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis. International Immunopharmacology 59, pages 86-96.
Crossref
Teresa Nguyen, Naze Avci, Dong Shin, Naiara Martinez-Velez & Hong Jiang. (2018) Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses. Cancers 10:6, pages 171.
Crossref
Wilfred Ngwa, Omoruyi Credit Irabor, Jonathan D. Schoenfeld, Jürgen Hesser, Sandra Demaria & Silvia C. Formenti. (2018) Using immunotherapy to boost the abscopal effect. Nature Reviews Cancer 18:5, pages 313-322.
Crossref
Urska Kamensek, Maja Cemazar, Ursa Lampreht Tratar, Katja Ursic & Gregor Sersa. (2018) Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model. Cancer Immunology, Immunotherapy 67:5, pages 785-795.
Crossref
Anna E. Czapar, Brylee David B. Tiu, Frank A. Veliz, Jonathan K. Pokorski & Nicole F. Steinmetz. (2018) Slow-Release Formulation of Cowpea Mosaic Virus for In Situ Vaccine Delivery to Treat Ovarian Cancer. Advanced Science 5:5, pages 1700991.
Crossref
C. Burkart, A. Mukhopadhyay, S. A. Shirley, R. J. Connolly, J. H. Wright, A. Bahrami, J. S. Campbell, R. H. Pierce & D. A. Canton. (2018) Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters. Gene Therapy 25:2, pages 93-103.
Crossref
Myunggi An, Chunsong Yu, Jingchao Xi, Joyce Reyes, Guangzhao Mao, Wei-Zen Wei & Haipeng Liu. (2018) Induction of necrotic cell death and activation of STING in the tumor microenvironment via cationic silica nanoparticles leading to enhanced antitumor immunity . Nanoscale 10:19, pages 9311-9319.
Crossref
Jonathan P. O. Hebb, Adriane R. Mosley, Felipe Vences-Catalán, Narendiran Rajasekaran, Anna Rosén, Peter Ellmark & Dean W. Felsher. (2017) Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression. Cancer Immunology, Immunotherapy 67:1, pages 47-60.
Crossref
Sheung P. Ng & Judith T. Zelikoff. 2018. Immunotoxicity Testing. Immunotoxicity Testing 169 180 .
Rocio Garcia-Carbonero, Ramon Salazar, Ignacio Duran, Ignacio Osman-Garcia, Luis Paz-Ares, Juan M. Bozada, Valentina Boni, Christine Blanc, Len Seymour, John Beadle, Simon Alvis, Brian Champion, Emiliano Calvo & Kerry Fisher. (2017) Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection. Journal for ImmunoTherapy of Cancer 5:1.
Crossref
Marijo Bilusic & James L Gulley. (2017) Editorial: Local Immunotherapy: A Way to Convert Tumors From “Cold” to “Hot”. JNCI: Journal of the National Cancer Institute 109:12.
Crossref
Karin L. Lee, Abner A. Murray, Duc H. T. Le, Mee Rie Sheen, Sourabh Shukla, Ulrich Commandeur, Steven Fiering & Nicole F. Steinmetz. (2017) Combination of Plant Virus Nanoparticle-Based in Situ Vaccination with Chemotherapy Potentiates Antitumor Response. Nano Letters 17:7, pages 4019-4028.
Crossref
Heath B. Mackley, Jason Liu, Junjia Zhu, Henry Wagner, Giampaolo Talamo, Todd D. Schell, Colette Pameijer, Rogerio I. Neves, Bryan Anderson, Kathleen M. Kokolus, Jeffrey Sivik, Carol A. Mallon, Kristian M. Koller & Joseph J. Drabick. (2017) Improved infield response rates and overall survival in patients with metastatic melanoma receiving higher biological equivalent doses of radiation with ipilimumab. Journal of Radiation Oncology 6:2, pages 215-223.
Crossref
Peter Ellmark, Sara M. Mangsbo, Christina Furebring, Per Norlén & Thomas H. Tötterman. (2016) Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation. Cancer Immunology, Immunotherapy 66:1, pages 1-7.
Crossref
João Paulo Portela Catani, Ruan F.V. Medrano, Aline Hunger, Paulo Del Valle, Sandy Adjemian, Daniela Bertolini Zanatta, Guido Kroemer, Eugenia Costanzi-Strauss & Bryan E. Strauss. (2016) Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma. Translational Oncology 9:6, pages 565-574.
Crossref
Caroline J. Breitbach, Brian D. Lichty & John C. Bell. (2016) Oncolytic Viruses: Therapeutics With an Identity Crisis. EBioMedicine 9, pages 31-36.
Crossref
Liv-Marie Eike, Brynjar Mauseth, Ketil André Camilio, Øystein Rekdal & Baldur Sveinbjørnsson. (2016) The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma. PLOS ONE 11:2, pages e0148980.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.